Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J7173 Injection. concizumab-mtci, 0.5 milligrams

J Codes (Drugs)

Also known as: concizumab, TFPI inhibitor, monoclonal antibody

Injection of concizumab-mtci, a monoclonal antibody against tissue factor pathway inhibitor, supplied as 0.5 milligrams per dose for hemophilia management.

In Plain Language

hemophilia treatment; clotting enhancement therapy

Clinical Context

Indicated for prophylaxis of breakthrough bleeding in hemophilia A or B patients with inhibitors, enhances coagulation through TFPI pathway inhibition.

RVU Information

CPT J7173 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

HematologyHemophilia Specialty Clinic

Frequently Asked Questions

What is CPT code J7173?

CPT J7173 (Injection. concizumab-mtci, 0.5 milligrams) is a J Codes (Drugs) code. Injection of concizumab-mtci, a monoclonal antibody against tissue factor pathway inhibitor, supplied as 0.5 milligrams per dose for hemophilia management.

How is J7173 administered?

CPT J7173 is administered by a healthcare provider, typically via injection or infusion. Indicated for prophylaxis of breakthrough bleeding in hemophilia A or B patients with inhibitors, enhances coagulation through TFPI pathway inhibition. It is used by Hematology, Hemophilia Specialty Clinic.

When is CPT J7173 used?

Indicated for prophylaxis of breakthrough bleeding in hemophilia A or B patients with inhibitors, enhances coagulation through TFPI pathway inhibition.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.